Tumor heterogeneity: preclinical models, emerging technologies, and future applications

Area of Science:

• Oncology
• Genomics
• Immunology

Background:

• Tumor heterogeneity encompasses variations in cancer cell morphology, gene expression, metabolism, and metastatic potential.
• It also includes the tumor immune microenvironment and cellular interactions driving tumor ecosystem evolution.
• Heterogeneity is a major challenge in cancer, contributing to treatment resistance, metastasis, and recurrence.

Purpose of the Study:

• To review the role of models and genomic technologies in understanding tumor heterogeneity.
• To explore heterogeneity's contribution to lethal cancer outcomes and therapeutic challenges.
• To highlight how tumor-immune microenvironment interactions can be leveraged for immunotherapy.

Main Methods:

• Review of existing models of tumor heterogeneity.
• Analysis of single-cell and spatial genomic technologies.
• Examination of tumor-immune microenvironment dynamics.

Main Results:

• Heterogeneity is a critical factor impairing solid tumor therapy efficacy.
• Tumor cells dynamically evolve due to interactions within the tumor immune microenvironment.
• Advanced genomic technologies are crucial for understanding heterogeneity.

Conclusions:

• A multidisciplinary approach with bioinformatic tools is needed for integrated knowledge of tumor heterogeneity.
• Leveraging tumor-immune interactions can enhance immune recognition and immunotherapy.
• Personalized and more efficient cancer therapies require a deep understanding of tumor heterogeneity.